Angiogenic profiling in patients with advanced well-differentiated pancreatic neuroendocrine tumors treated with everolimus

被引：0
|
作者：
Cella, C. A. [1 ]
Spada, F. [1 ]
Galdy, S. [1 ]
Frezza, A. M. [1 ]
Catapano, M. [1 ]
Funicelli, L. [1 ]
Calleri, A. [1 ]
Zorzino, L. [1 ]
Mancuso, P. [1 ]
Radice, D. [1 ]
Fazio, N. [1 ]
机构：
[1] European Inst Oncol, Gastrintestinal Tumors & Neuroendocrine Tumors Un, Milan, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31260-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2344
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [31] Updates on well-differentiated neuroendocrine tumors
    Reidy-Lagunes, Diane
    Wyluda, Ed
    SALUD I CIENCIA, 2012, 18 (08): : 737 - 740
  • [32] Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
    Li, Su-Chen
    Essaghir, Ahmed
    Martijn, Cecile
    Lloyd, Ricardo V.
    Demoulin, Jean-Baptiste
    Oberg, Kjell
    Giandomenico, Valeria
    MODERN PATHOLOGY, 2013, 26 (05) : 685 - 696
  • [33] Comparison of Methods for Grading Gastrointestinal and Pancreatic Well-Differentiated Neuroendocrine Tumors
    Goodell, Pamela P.
    Krasinskas, Alyssa M.
    Hartman, Douglas J.
    GASTROENTEROLOGY, 2011, 140 (05) : S875 - S875
  • [34] Well-Differentiated Pancreatic Neuroendocrine Tumors: Prognostic Significance of Pathological Parameters
    Perez-Casanova, L.
    Serrano, T.
    Navas, C.
    Ruiz, N.
    Gomez, A.
    Loayza, C.
    Nienow, C.
    Salazar, R.
    Villabona, C.
    Valls, C.
    Fabregat, J.
    Condom, E.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 250 - 250
  • [35] Recurrence After Curative Resection for Well-Differentiated Pancreatic Neuroendocrine Tumors
    Kimura, H.
    Ohtsuka, T.
    Date, K.
    Fujimoto, T.
    Matsunaga, T.
    Watanabe, Y.
    Tamura, K.
    Miyasaka, Y.
    Yamada, D.
    Takahata, S.
    Igarashi, H.
    Ito, T.
    Oda, Y.
    Tanaka, M.
    PANCREAS, 2014, 43 (08) : 1379 - 1379
  • [36] PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from Heal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma
    Sangoi, Ankur R.
    Ohgami, Robert S.
    Pai, Rish K.
    Beck, Andrew H.
    McKenney, Jesse K.
    Pai, Reetesh K.
    MODERN PATHOLOGY, 2011, 24 (03) : 412 - 424
  • [37] IFN-α in advanced well-differentiated neuroendocrine tumors: the neglected drug?
    Amoroso, Vito
    Pavel, Marianne
    Claps, Melanie
    Roca, Elisa
    Ravanelli, Marco
    Maroldi, Roberto
    Oberg, Kjell
    Berruti, Alfredo
    FUTURE ONCOLOGY, 2018, 14 (10) : 897 - 899
  • [38] Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Dasari, Arvind
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [39] Characteristics of Patients with Well-Differentiated Metastatic Lung Neuroendocrine Tumors
    Chougnet, C.
    Guigay, J.
    Borget, I
    Leboulleux, S.
    Duvillard, P.
    Deandreis, D.
    Dromain, C.
    Schlumberger, M.
    Ducreux, M.
    Baudin, E.
    NEUROENDOCRINOLOGY, 2011, 94 : 21 - 21
  • [40] Upregulation of Peroxiredoxin-2 in Well-Differentiated Pancreatic Neuroendocrine Tumors and Its Utility as a Biomarker for Predicting the Response to Everolimus
    Kim, Eui Joo
    Kim, Yoon Jae
    Lee, Hye In
    Jeong, Seok-Hoo
    Nam, Hyo Jung
    Cho, Jae Hee
    ANTIOXIDANTS, 2020, 9 (11) : 1 - 13
12345